COMPLETE KIT INCLUDEDbacteriostatic water, syringes, protocol and guide with every order

Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•

Research guide · Cellular Energy

MOTS-c — research protocol

Mitochondrial-derived 16-amino-acid peptide encoded within the 12S rRNA. Regulates AMPK signaling, glucose homeostasis, insulin sensitivity and mitochondrial biogenesis. Studied for metabolic health, exercise capacity and longevity.

Evidence boundary

This guide summarizes study areas and sources associated with the compound. BioPeptideX does not convert experimental information into a clinical regimen or recommend an individual dose, frequency, route or duration.

Catalog presentations

10mg5mg15mg20mg40mg

Concentration table

Mathematical reference only; this is not a dosing recommendation.

Resulting concentration5.00 mg/mL
On a U-100 syringe · 1 unit contains0.050 mg

Research areas

  • Mitochondrial-derived peptide (MDP) — activates AMPK
  • Improves insulin sensitivity and glucose homeostasis in preclinical studies
  • Boosts mitochondrial biogenesis and exercise endurance
  • Studied for metabolic syndrome, obesity and longevity
  • Lyophilized powder, 99% HPLC verified purity
  • COA included with every vial

Most-cited research protocols

Educational information based on research protocols and literature; it does not replace guidance from a healthcare professional.

MOTS-c is a 16-amino-acid peptide made by mitochondria, studied for its role in cellular energy handling during stress, exercise, or aging. It primarily activates AMPK, a key energy switch inside cells.

DoseFrequencyDurationRoute
Lower-end starting tier5 mg2x per week4 weeksSubcutaneous injection
Standard tier5 mg3x per week4-6 weeksSubcutaneous injection
Higher tier10 mg2-3x per week6-8 weeksSubcutaneous injection

Cycle: Conservative: 4 weeks on, 4 weeks off. Standard: 6 weeks on, 4-6 weeks off. Extended: 8 weeks on, 6-8 weeks off.

Benefits and research observations: In weeks 1-2, steadier daytime energy is reported. By weeks 3-4, workout tolerance and recovery may improve, and body-composition shifts might appear by weeks 4-6.

Handling and storage

Store unreconstituted product according to its label and maintain the cold chain where applicable. After any preparation, follow only validated instructions for the specific product and diluent. Do not use if packaging is damaged or the solution shows particles or unexpected changes.

Warnings

Do not use this page for self-diagnosis or self-medication. Pregnancy, breastfeeding, minors, cancer history, allergies, active disease and concurrent treatments require individual professional evaluation.

Published sources

  1. 1.Lee C, et al. Cell Metab, 2015.
  2. 2.Kim KH, et al. Free Radic Biol Med, 2018.
  3. 3.Reynolds JC, et al. Nat Commun, 2021.